We expect continued development in our medical gadget engineering segment. And, with the added capital from operations, along with the recent strategic purchase received from APT, we plan to advance our proprietary medical device projects as well. Related StoriesApoE4-carrying men with Alzheimer's disease at risk of brain bleedsDiscovery can offer clues to how some viruses control expression of genetic materialCHOP researchers delay symptoms, prolong lifespan in animal model of Batten diseaseALS is a fatal and progressive, neurodegenerative disorder affecting the electric motor neurons in the central anxious system.The meeting call will also be webcast on the Investors section of Alkermes' site at In addition, a replay of the conference call will be accessible from 10:30 a.m. EDT on Tuesday, April 8, 2014, through 5:00 p.m. EDT on Tuesday, April 15, 2014, and could be accessed at Alkermes' internet site or by dialing +1 888 843 7419 for U.S. Callers and +1 630 652 3042 for international callers. The replay access code is 6037988.. A fact-based media briefing about bipolar disorder in Nova Scotia Around 26,000 Nova Scotians live with bipolar disorder. Stigmatized in popular tradition Often, the experience of bipolar disorder varies from one person to the next and almost always includes a drastic impact on how individuals think, function and behave. Bipolar Disorder significantly affects the entire lives of those who have the illness in addition to their families, friends, colleagues and employers.